Obstetrics, gynecology and reproductive medicine guidelines

Menopause

PubMed Free Full Text

Menopause, hormone replacement therapy

 

Asia

• Climacteric
  • Updated clinical recommendations for the use of tibolone in Asian women [2010]

Australasia

• Australasian Menopause Society
  • Menopause Management

Australia

• BMC Women's Health
  • Menopause and the influence of culture: another gap for Indigenous Australian women? [2012]

Canada

• Canadian Agency for Drugs and Technologies in Health
  • Oral Progesterone for the Treatment of Menopausal Symptoms: A Review of the Clinical Evidence [2014]

Cochrane

• Cochrane Library
  • Short-term and long-term effects of tibolone in postmenopausal women
  • Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution
  • Long-term hormone therapy for perimenopausal and postmenopausal women
  • Hormone replacement therapy for women with type 1 diabetes mellitus

Europe

• European Menopause and Andropause Society
  • A model of care for healthy menopause and ageing: EMAS position statement [2016]
  • EMAS position statement: The ten point guide to the integral management of menopausal health [2015]

• European Society of Human Reproduction and Embryology
  • Perimenopausal risk factors and future health [2011]

Germany

• Archives of Gynecology and Obstetrics
  • Hormone therapy in perimenopause and postmenopause (HT). Interdisciplinary S3 Guideline, Association of the Scientific Medical Societies in Germany AWMF 015/062-short version [2011]

• Deutsches Ärzteblatt International
  • The Treatment of Climacteric Symptoms [2012]

India

• Journal of Mid-Life Health
  • Clinical practice guidelines on menopause: An executive summary and recommendations [2013]

International

• Climacteric
  • Global Consensus Statement on Menopausal Hormone Therapy [2013]

• Fertility and Sterility
  • Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging [2012]

Italy

• BMC Women's Health
  • Informing women about hormone replacement therapy: the Consensus conference statement [2009]

Poland

• Przeglad Menopauzalny = Menopause Review
  • Guidelines for menopausal hormone therapy: Recommendations of the Polish Menopause and Andropause Society – state of knowledge as of December 2013 [2014]

United Kingdom

• National Institute for Health and Care Excellence
  • Menopause (Quality standard) [2017]
  • Oestrogen deficiency symptoms in postmenopausal women: conjugated oestrogens and bazedoxifene acetate [2016]
  • Menopause: diagnosis and management [2015]
  • Menopause

• Royal College of Nursing
  • Nurse specialist in menopause [2017]
  • Menopause [2017]
  • Menopause: Lifestyle and therapeutic approaches [2013]

• Royal College of Obstetricians and Gynaecologists
  • Ovarian Cysts in Postmenopausal Women [2016]

United States of America

• Agency for Healthcare Research and Quality
  • Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women [2017]
  • Menopausal Symptoms: Comparative Effectiveness of Therapies [2015]
  • Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions [2012]

• American Association of Clinical Endocrinologists
  • American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on Menopause–2017 Update [2017]
  • American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of menopause [2011]

• American College of Obstetricians and Gynecologists
  • Compounded Bioidentical Menopausal Hormone Therapy [2012]

• American Society for Reproductive Medicine
  • Menopause

• Endocrine Society
  • Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline [2015]
  • Postmenopausal Hormone Therapy: An Endocrine Society Scientific Statement [2010]

• National Cancer Institute
  • Menopausal Hormone Therapy and Cancer

• North American Menopause Society
  • The 2017 hormone therapy position statement of The North American Menopause Society [2017]
  • Scientific Background Report for the 2017 Hormone Therapy Position Statement of The North American Menopause Society [2017]
  • Use of compounded hormone therapy in the United States: report of The North American Menopause Society Survey [2015]
  • The North American Menopause Society Statement on Continuing Use of Systemic Hormone Therapy After Age 65 [2015]
  • NAMS supports judicious use of systemic hormone therapy for women aged 65 years and older [2015]
  • Why the product labeling for low-dose vaginal estrogen should be changed [2014]
  • The North American Menopause Society Recommendations for Clinical Care of Midlife Women [2014]
  • Algorithm and mobile app for menopausal symptom management and hormonal/non-hormonal therapy decision making: a clinical decision-support tool from The North American Menopause Society [2014]
  • Clinical Care Recommendations

• Obstetrics & Gynecology Clinics of North America
  • The SWAN Song: Study of Women’s Health Across the Nation’s Recurring Themes [2011]
  • Reproductive Hormones and the Menopause Transition [2011]
  • Physical Activity and Health During the Menopausal Transition [2011]
  • Menstruation and the Menopause Transition [2011]
  • Adrenal Androgens and the Menopausal Transition [2011]

• U.S. Preventive Services Task Force
  • Hormone Therapy in Postmenopausal Women: Primary Prevention of Chronic Conditions [2017]

{Related topics}

• Guidelines
  • Osteoporosis
  • Menopause: alternative therapy
  • Menopause, hormone replacement therapy: hot flashes, vasomotor symptoms
  • Menopause, hormone replacement therapy: abnormal bleeding
  • Menopause, hormone replacement therapy, sexual disorders
  • Menopause, hormone replacement therapy, cardiovascular disease
  • Menopause, hormone replacement therapy, breast cancer
  • Menopause, hormone replacement therapy, brain disease